ArticleCureus2025
Inverted Urothelial Papilloma in a Young Woman: A Case Report and Review of Diagnostic Advances.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inverted urothelial papilloma (IUP) is an uncommon benign urothelial tumor characterized by an endophytic growth pattern. While it most commonly affects older male patients, we report the case of a young female patient with a bladder lesion located on the right lateral wall, an exceptionally rare clinical presentation in terms of age, sex, and tumor location. Such unusual presentations offer valuable learning opportunities and remind clinicians to consider rare benign entities in the differential diagnosis of bladder tumors. Accurate differentiation from urothelial carcinoma (UC) remains essential due to overlapping histological features. We emphasize the critical role of imaging, histopathology, and immunohistochemistry in reaching a definitive diagnosis, while highlighting the potential of emerging methods to enhance clinical decision-making. As radiomics and artificial intelligence (AI) continue to advance, they may significantly influence diagnostic approaches and future therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.